06/18/2026
Congratulations to Cycle Pharmaceuticals on the acquisition of Applied Therapeutics and this exciting step forward in supporting patients with rare diseases.
Growth moments like these require more than operational ex*****on alone. They depend on the right people, leadership alignment, and specialized expertise to continue moving innovation forward.
We look forward to seeing the impact this next chapter creates for patients, teams, and the broader life sciences community.
Read more: https://loom.ly/-l1ngBQ
CAMBRIDGE, UK and DETROIT, MICHIGAN – 30th January 2026 – Cycle Group Holdings Limited (“Cycle” or “Parent”) today announces that AT2B, Inc., a Delaware corporation (“Purchaser”) and indirect wholly owned subsidiary of Cycle, has extended the expiration date of its tender offer to pu...